Meanwhile, TPD52L1-ROS1 fusion was reported in NSCLC, and the breakpoint of ROS1 and TPD52L1 was located in intron 32 and intron 3, respectively [24]. The gene discussed is ROS1; the disease is non-small cell lung carcinoma.